Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Blueberries Medical Corp

Healthcare US BBRRF

0.007USD
-0.003(30.00%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.0070.007
LowHigh

52 Week Range

0.00560.02
LowHigh

Fundamentals

  • Previous Close 0.01
  • Market Cap6.44M
  • Volume1100
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.24393M
  • Revenue TTM0.41M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.15M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.14853M -1.63537M -1.46788M -5.14701M -4.94011M
Minority interest - - - - -
Net income -1.14853M -1.63537M -1.46788M -5.14701M -4.94011M
Selling general administrative 0.90M 1.22M 1.23M 0.58M 3.47M
Selling and marketing expenses 0.07M 0.09M - - -
Gross profit 0.16M 0.08M -0.01772M -0.24545M 0.06M
Reconciled depreciation 0.11M 0.15M 0.30M 0.83M 0.71M
Ebit -1.14853M -1.37153M -1.64059M -1.78921M -4.12464M
Ebitda -1.04334M -1.22179M -0.81147M -4.04922M -4.10668M
Depreciation and amortization 0.11M 0.15M - - -
Non operating income net other - - - - -
Operating income -0.91312M -1.37631M -1.64059M -1.78921M -4.12464M
Other operating expenses 1.38M 1.66M - -0.02430M -0.02430M
Interest expense 0.00000M 0.26M 0.36M 0.27M 0.12M
Tax provision - - - - 0.00000M
Interest income - - - - -
Net interest income 0.00000M -0.26384M -0.36008M -0.26942M -0.11969M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.47M 0.29M 0.24M 0.14M 0.07M
Total operating expenses 1.08M 1.46M 1.88M 1.93M 4.19M
Cost of revenue 0.31M 0.20M 0.25M 0.38M 0.00358M
Total other income expense net -0.23541M -0.25906M 0.53M -3.08839M -0.69578M
Discontinued operations - - - - -
Net income from continuing ops -1.14853M -1.63537M -1.46788M -5.14701M -4.94011M
Net income applicable to common shares - - -1.46788M -5.14701M -4.94011M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 1.38M 2.42M 3.35M 3.59M 7.27M
Intangible assets 0.00000M - - - -
Earning assets - - - - -
Other current assets 0.30M - 0.46M - -
Total liab 0.55M 0.47M 1.89M 2.16M 3.38M
Total stockholder equity 0.83M 1.95M 1.47M 1.43M 3.89M
Deferred long term liab - - - - -
Other current liab 0.06M - 0.06M 0.37M 0.85M
Common stock 20.23M - 18.25M 16.78M 13.64M
Capital stock 20.23M 20.23M 18.25M 16.78M 13.64M
Retained earnings -25.66243M -24.51390M -22.87852M -21.41065M -16.26364M
Other liab - - - - -
Good will - - - - -
Other assets - - 0.38M 0.43M 2.56M
Cash 0.07M 0.82M 1.41M 1.34M 0.31M
Cash and equivalents - - - - -
Total current liabilities 0.55M 0.46M 1.75M 1.94M 2.10M
Current deferred revenue - - - - -
Net debt -0.05464M - - - 0.53M
Short term debt 0.01M - - - -
Short long term debt - - 1.15M 1.11M -
Short long term debt total 0.01M - - - -
Other stockholder equity 6.99M - -0.73678M -0.63721M 4.03M
Property plant equipment - - 0.79M 1.60M 3.35M
Total current assets 1.00M 1.91M 2.19M 1.56M 0.52M
Long term investments - - - 0.00000M 0.57M
Net tangible assets - - 1.47M 1.43M 3.05M
Short term investments - - - - -
Net receivables 0.39M 0.11M 0.26M 0.20M 0.20M
Long term debt - - - - 0.84M
Inventory 0.25M 0.26M 0.01M - -
Accounts payable 0.47M - 0.45M 0.30M 0.93M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.72587M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.38M 0.51M 1.17M 2.03M 6.75M
Capital lease obligations 0.01M 0.01M 0.19M 0.33M 0.65M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.00900M 0.38M 0.10M -0.04877M -0.61104M
Change to liabilities - - 0.00000M -0.43415M 0.22M
Total cashflows from investing activities 0.00900M 0.38M 0.10M -0.04877M -0.61104M
Net borrowings -0.00195M -1.44191M -0.12083M -0.13819M 0.78M
Total cash from financing activities -0.00195M 0.54M 1.35M 2.77M 0.78M
Change to operating activities - - -0.08276M -0.00843M -0.02114M
Net income -1.14853M -1.63537M -1.46788M -5.14701M -4.94011M
Change in cash -0.75208M -0.59461M 0.07M 1.04M -2.35968M
Begin period cash flow 0.82M 1.41M 1.34M 0.31M 2.67M
End period cash flow 0.07M 0.82M 1.41M 1.34M 0.31M
Total cash from operating activities -0.79685M -1.33254M -1.46855M -1.68026M -2.39016M
Issuance of capital stock 0.00000M 1.98M 1.47M 2.84M 0.00000M
Depreciation 0.11M 0.15M 0.30M 0.83M 0.71M
Other cashflows from investing activities 0.00900M 0.41M - - 0.26M
Dividends paid - - - - -
Change to inventory 0.02M -0.24840M -0.01231M 0.00000M 0.00850M
Change to account receivables -0.11215M -0.07523M - 0.07M -0.02425M
Sale purchase of stock - - - - -
Other cashflows from financing activities - -0.00312M - -0.06353M -0.06353M
Change to netincome - - -0.21424M 3.01M 1.65M
Capital expenditures 0.00000M 0.02M 0.00000M 0.00954M 0.83M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.00178M -0.33598M -0.08276M -0.37143M 0.18M
Stock based compensation 0.05M 0.11M 0.13M -0.33956M 0.81M
Other non cash items 0.20M 0.38M 0.23M 0.29M 0.19M
Free cash flow -0.79685M -1.35489M -1.46855M -1.72903M -3.00120M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BBRRF
Blueberries Medical Corp		 -0.003 30.00% 0.007 - - 15.55 9.27 11.93 -0.8628
ZTS
Zoetis Inc		 -2.82 3.58% 75.89 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 - -% 42.94 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. The company produces psychoactive and non-psychoactive cannabis derivatives. It also distributes functional supplements, wellness products, and natural ingredients. Blueberries Medical Corp. is based in Vancouver, Canada.

Blueberries Medical Corp

8500 West Georgia Street, Vancouver, BC, Canada, V6C 3E8

Key Executives

Name Title Year Born
Mr. Facundo Garreton Chairman & Interim CEO NA
Mr. Ian D. Atacan B.Sc., C.M.A., C.P.A., CMA, CPA, M.B.A., MBA Chief Financial Officer NA
Mr. Jose Maria Forero Pres of Latin American Operations NA
Mr. Camilo Villalba Gomez Co Founder & Consultant NA
Mr. Fabian Salazar Technical Director NA
Dr. Patricio A. Stocker Sr. Strategic Consultant NA
Mr. Facundo Garreton Executive Chairman & CEO 1975
Mr. Guillermo P. Rodriguez Chief Financial Officer NA
Mr. Facundo Garreton Executive Chairman & CEO 1974
Mr. Thomas P. Rodriguez Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.